725 related articles for article (PubMed ID: 24636868)
1. 3D cell culture systems modeling tumor growth determinants in cancer target discovery.
Thoma CR; Zimmermann M; Agarkova I; Kelm JM; Krek W
Adv Drug Deliv Rev; 2014 Apr; 69-70():29-41. PubMed ID: 24636868
[TBL] [Abstract][Full Text] [Related]
2. The multicellular tumor spheroid model for high-throughput cancer drug discovery.
LaBarbera DV; Reid BG; Yoo BH
Expert Opin Drug Discov; 2012 Sep; 7(9):819-30. PubMed ID: 22788761
[TBL] [Abstract][Full Text] [Related]
3. Tissue-engineered 3D tumor angiogenesis models: potential technologies for anti-cancer drug discovery.
Chwalek K; Bray LJ; Werner C
Adv Drug Deliv Rev; 2014 Dec; 79-80():30-9. PubMed ID: 24819220
[TBL] [Abstract][Full Text] [Related]
4. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
[TBL] [Abstract][Full Text] [Related]
5. Alternation of adriamycin penetration kinetics in MCF-7 cells from 2D to 3D culture based on P-gp expression through the Chk2/p53/NF-κB pathway.
Lu M; Zhou F; Hao K; Liu J; Chen Q; Ni P; Zhou H; Wang G; Zhang J
Biochem Pharmacol; 2015 Jan; 93(2):210-20. PubMed ID: 25478729
[TBL] [Abstract][Full Text] [Related]
6. Experimental anti-tumor therapy in 3-D: spheroids--old hat or new challenge?
Friedrich J; Ebner R; Kunz-Schughart LA
Int J Radiat Biol; 2007; 83(11-12):849-71. PubMed ID: 18058370
[TBL] [Abstract][Full Text] [Related]
7. Development of a magnetic 3D spheroid platform with potential application for high-throughput drug screening.
Guo WM; Loh XJ; Tan EY; Loo JS; Ho VH
Mol Pharm; 2014 Jul; 11(7):2182-9. PubMed ID: 24842574
[TBL] [Abstract][Full Text] [Related]
8. Formation of multicellular tumor spheroids induced by cyclic RGD-peptides and use for anticancer drug testing in vitro.
Akasov R; Zaytseva-Zotova D; Burov S; Leko M; Dontenwill M; Chiper M; Vandamme T; Markvicheva E
Int J Pharm; 2016 Jun; 506(1-2):148-57. PubMed ID: 27107900
[TBL] [Abstract][Full Text] [Related]
9. Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing.
Gong X; Lin C; Cheng J; Su J; Zhao H; Liu T; Wen X; Zhao P
PLoS One; 2015; 10(6):e0130348. PubMed ID: 26090664
[TBL] [Abstract][Full Text] [Related]
10. Engineering a scaffold-free 3D tumor model for in vitro drug penetration studies.
Ong SM; Zhao Z; Arooz T; Zhao D; Zhang S; Du T; Wasser M; van Noort D; Yu H
Biomaterials; 2010 Feb; 31(6):1180-90. PubMed ID: 19889455
[TBL] [Abstract][Full Text] [Related]
11. Metabolic effects of antiangiogenic drugs in tumors: therapeutic implications.
Quintieri L; Selmy M; Indraccolo S
Biochem Pharmacol; 2014 May; 89(2):162-70. PubMed ID: 24607274
[TBL] [Abstract][Full Text] [Related]
12. 3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions.
Wenzel C; Riefke B; Gründemann S; Krebs A; Christian S; Prinz F; Osterland M; Golfier S; Räse S; Ansari N; Esner M; Bickle M; Pampaloni F; Mattheyer C; Stelzer EH; Parczyk K; Prechtl S; Steigemann P
Exp Cell Res; 2014 Apr; 323(1):131-143. PubMed ID: 24480576
[TBL] [Abstract][Full Text] [Related]
13. Emerging tumor spheroids technologies for 3D in vitro cancer modeling.
Rodrigues T; Kundu B; Silva-Correia J; Kundu SC; Oliveira JM; Reis RL; Correlo VM
Pharmacol Ther; 2018 Apr; 184():201-211. PubMed ID: 29097309
[TBL] [Abstract][Full Text] [Related]
14. A Novel Multiparametric Drug-Scoring Method for High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
Cribbes S; Kessel S; McMenemy S; Qiu J; Chan LL
SLAS Discov; 2017 Jun; 22(5):547-557. PubMed ID: 28346096
[TBL] [Abstract][Full Text] [Related]
15. Targeting antioxidants for cancer therapy.
Glasauer A; Chandel NS
Biochem Pharmacol; 2014 Nov; 92(1):90-101. PubMed ID: 25078786
[TBL] [Abstract][Full Text] [Related]
16. RNAi High-Throughput Screening of Single- and Multi-Cell-Type Tumor Spheroids: A Comprehensive Analysis in Two and Three Dimensions.
Fu J; Fernandez D; Ferrer M; Titus SA; Buehler E; Lal-Nag MA
SLAS Discov; 2017 Jun; 22(5):525-536. PubMed ID: 28277887
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic and molecular differences of anticancer agents on 2D and 3D cell culture.
Alwahsh M; Al-Doridee A; Jasim S; Awwad O; Hergenröder R; Hamadneh L
Mol Biol Rep; 2024 Jun; 51(1):721. PubMed ID: 38829450
[TBL] [Abstract][Full Text] [Related]
18. High-throughput screening in multicellular spheroids for target discovery in the tumor microenvironment.
Calpe B; Kovacs WJ
Expert Opin Drug Discov; 2020 Aug; 15(8):955-967. PubMed ID: 32364413
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of a human three-dimensional chondrosarcoma culture for in vitro drug testing.
Voissiere A; Jouberton E; Maubert E; Degoul F; Peyrode C; Chezal JM; Miot-Noirault É
PLoS One; 2017; 12(7):e0181340. PubMed ID: 28704566
[TBL] [Abstract][Full Text] [Related]
20. High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment.
Yoshii Y; Furukawa T; Waki A; Okuyama H; Inoue M; Itoh M; Zhang MR; Wakizaka H; Sogawa C; Kiyono Y; Yoshii H; Fujibayashi Y; Saga T
Biomaterials; 2015 May; 51():278-289. PubMed ID: 25771018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]